Patents by Inventor Barry Pius Kiely

Barry Pius Kiely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9821015
    Abstract: According to the present invention there are provided methods of regulating the immune system of a companion animal and methods of improving the digestion of a companion animal, wherein each of said methods comprises administering to a companion animal a probiotic bacteria strain of the genus Bifidobacteria.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: November 21, 2017
    Assignee: Mars, Incorporated
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 9580680
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: February 28, 2017
    Assignee: Mars, Incorporated
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 9404162
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Bifidobacteria obtainable by isolation from resected and washed feline gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: August 2, 2016
    Assignee: MARS, INCORPORATED
    Inventors: Thomas William-Maxwell Boileau, Barry Pius Kiely, Liam Diarmuid O'Mahony, John MacSharry, Greg Dean Sunvold
  • Publication number: 20160002590
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 7, 2016
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers, John Kevin Collins
  • Patent number: 9192177
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed feline gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: November 24, 2015
    Assignee: The Iams Company
    Inventors: Thomas William-Maxwell Boileau, Barry Pius Kiely, Liam Diarmuid O'Mahony, John MacSharry, Greg Dean Sunvold
  • Publication number: 20150190437
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria.
    Type: Application
    Filed: October 17, 2014
    Publication date: July 9, 2015
    Applicants: THE IAMS COMPANY, ALIMENTARY HEALTH LIMITED
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8900569
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 2, 2014
    Assignees: The Iams Company, Alimentary Health
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8900568
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 2, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8894991
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 25, 2014
    Assignee: The Iams Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8877178
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 4, 2014
    Assignees: The Iams Company, Alimentary Health Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8840880
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: September 23, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8809035
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium globosum of the present invention are also provided.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: August 19, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8802158
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Lactobacilli.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: August 12, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Publication number: 20130217600
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Application
    Filed: June 15, 2012
    Publication date: August 22, 2013
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Patent number: 8216563
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: July 10, 2012
    Assignee: The Procter & Gamble Company
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Patent number: 8034601
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Bifidobacteria obtainable by isolation from resected and washed feline gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria of the present invention are also provided.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: October 11, 2011
    Assignee: The Procter & Gamble Company
    Inventors: Thomas William-Mawell Boileau, Barry Pius Kiely, Liam Diarmuid O'Mahony, John MacSharry, Greg Dean Sunvold
  • Patent number: 7998473
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: August 16, 2011
    Assignee: The Procter & Gamble Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Publication number: 20110189146
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Lactobacilli.
    Type: Application
    Filed: June 25, 2010
    Publication date: August 4, 2011
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Publication number: 20110152117
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Application
    Filed: February 28, 2011
    Publication date: June 23, 2011
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Patent number: 7923000
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: April 12, 2011
    Assignee: The Procter & Gamble Company
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan